With the current operating strategy for phase II they need 30-40 people with a UTI to recruit and be treated. Stratify them into different dosing regimes. Path tests of a few days after. Independent review panel review 3 months. All done inside 8 months.
Phase III studies are likely to be much bigger, but seriously if you have sepsis secondary to a UTI you are dying without prompt effective treatment. You will take the treatment. If you are alive 3 days later the treatment worked. No long follow up. Lets say recruitment takes a year you are still done inside 18 months.
On top of this they will need probably another 6-9 months for the FDA to agree on trial design. Still on track.
- Forums
- ASX - By Stock
- Ann: R327 added to WHO List of Antibacterial Products
With the current operating strategy for phase II they need 30-40...
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RCE (ASX) to my watchlist
(20min delay)
|
|||||
Last
46.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $102.0M |
Open | High | Low | Value | Volume |
46.0¢ | 46.5¢ | 46.0¢ | $12.51K | 27.20K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 24508 | 46.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
46.5¢ | 9969 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 24508 | 0.460 |
6 | 193009 | 0.455 |
14 | 230566 | 0.450 |
2 | 112000 | 0.445 |
6 | 149120 | 0.440 |
Price($) | Vol. | No. |
---|---|---|
0.465 | 9969 | 1 |
0.470 | 9993 | 1 |
0.475 | 63800 | 3 |
0.480 | 41600 | 2 |
0.485 | 82243 | 1 |
Last trade - 15.56pm 18/07/2024 (20 minute delay) ? |
Featured News
RCE (ASX) Chart |